Stevens Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,162
| Closed | -$473K | – | 351 |
|
|
2024
Q3 | $473K | Sell |
4,162
-13,563
| -77% | -$1.61M | 0.07% | 121 |
|
|
2024
Q2 | $2.19M | Buy |
+17,725
| New | +$2.28M | 0.74% | 23 |
|
|
2023
Q4 | – | Sell |
-4,861
| Closed | -$500K | – | 309 |
|
|
2023
Q3 | $500K | Buy |
+4,861
| New | +$524K | 0.14% | 148 |
|
|
2022
Q3 | – | Sell |
-9,335
| Closed | -$851K | – | 164 |
|
|
2022
Q2 | $851K | Sell |
9,335
-48,032
| -84% | -$4.26M | 0.59% | 25 |
|
|
2022
Q1 | $4.71M | Buy |
57,367
+47,443
| +478% | +$3.74M | 1.03% | 22 |
|
|
2021
Q4 | $761K | Buy |
+9,924
| New | +$790K | 0.17% | 133 |
|
|
2021
Q2 | – | Sell |
-39,829
| Closed | -$2.93M | – | 213 |
|
|
2021
Q1 | $2.93M | Buy |
+39,829
| New | +$2.94M | 1.61% | 16 |
|
|
2020
Q4 | – | Sell |
-90,162
| Closed | -$7.14M | – | 203 |
|
|
2020
Q3 | $7.14M | Buy |
90,162
+28,150
| +45% | +$2.2M | 2.65% | 9 |
|
|
2020
Q2 | $4.58M | Buy |
+62,012
| New | +$4.67M | 1.69% | 25 |
|
|
2020
Q1 | – | Sell |
-181,297
| Closed | -$15.7M | – | 270 |
|
|
2019
Q4 | $15.7M | Buy |
181,297
+8,857
| +5% | +$727K | 1.47% | 6 |
|
|
2019
Q3 | $13.9M | Sell |
172,440
-205,141
| -54% | -$16.4M | 1.25% | 8 |
|
|
2019
Q2 | $30.2M | Buy |
+377,581
| New | +$28.9M | 1.35% | 4 |
|
|
2018
Q4 | – | Sell |
-273,798
| Closed | -$18.5M | – | 829 |
|
|
2018
Q3 | $18.5M | Buy |
+273,798
| New | +$17.4M | 0.68% | 29 |
|
|
2017
Q4 | – | Sell |
-84,082
| Closed | -$5.14M | – | 966 |
|
|
2017
Q3 | $5.14M | Sell |
84,082
-11,065
| -12% | -$671K | 0.19% | 156 |
|
|
2017
Q2 | $5.82M | Sell |
95,147
-154,335
| -62% | -$9.39M | 0.22% | 140 |
|
|
2017
Q1 | $15.1M | Buy |
+249,482
| New | +$15.1M | 0.57% | 30 |
|
|
2016
Q2 | – | Sell |
-49,452
| Closed | -$2.5M | – | 1048 |
|
|
2016
Q1 | $2.5M | Sell |
49,452
-127,182
| -72% | -$6.23M | 0.1% | 251 |
|
|
2015
Q4 | $8.9M | Buy |
176,634
+106,065
| +150% | +$5.35M | 0.35% | 79 |
|
|
2015
Q3 | $3.33M | Buy |
+70,569
| New | +$3.75M | 0.15% | 162 |
|
|
2015
Q2 | – | Sell |
-53,698
| Closed | -$2.94M | – | 1163 |
|
|
2015
Q1 | $2.94M | Sell |
53,698
-709,698
| -93% | -$40.2M | 0.1% | 214 |
|
|
2014
Q4 | $41.4M | Buy |
763,396
+522,444
| +217% | +$29.1M | 1.4% | 4 |
|
|
2014
Q3 | $13.6M | Buy |
240,952
+203,966
| +551% | +$11.5M | 0.41% | 65 |
|
|
2014
Q2 | $2.04M | Buy |
+36,986
| New | +$2.02M | 0.05% | 360 |
|
|
2013
Q3 | – | Sell |
-181,600
| Closed | -$8.05M | – | 1141 |
|
|
2013
Q2 | $8.05M | Buy |
+181,600
| New | +$8.11M | 0.27% | 106 |
|
Other funds holding MRK
Stevens Capital Management's MRK Position: Q4 2024 in Review
Stevens Capital Management sold out of Merck (MRK) in Q4 2024, closing a stake of 4,162 shares — an estimated $473K sold.
Stevens Capital Management first reported a position in MRK in Q2 2013 and held it in 24 quarters. The position peaked at $41.4M in Q4 2014. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.
- Stevens Capital Management reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
- Stevens Capital Management sold 4,162 Merck shares in Q4 2024, an estimated $473K.
- Stevens Capital Management first reported a position in Merck in Q2 2013 and held it in 24 quarters.
- Stevens Capital Management's Merck position peaked at $41.4M in Q4 2014.
- 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.
Based on Stevens Capital Management's 13F filing for Q4 2024, filed 11 Feb 2025.